Target intelligence / Profile preview

Cellular double-stranded DNA (dsDNA) (dsDNA)

Target
dsDNA
Molecular classification
Nucleic acid, Genetic material
01

Overview

Cellular double-stranded DNA (dsDNA) is the fundamental molecule that stores and transmits genetic information within the nucleus and mitochondria of eukaryotic cells (Nature Education, 2014). It consists of two polynucleotide chains coiled around each other to form a double helix, stabilized by hydrogen bonds between complementary nitrogenous bases. As a therapeutic target, dsDNA is primarily exploited in cancer treatment through the use of cytotoxic agents that induce structural damage, such as alkylating agents, cross-linkers, and intercalators (National Cancer Institute, 2023). These interactions interfere with essential processes like DNA replication and transcription, leading to cell cycle arrest and programmed cell death (StatPearls, 2023). Additionally, dsDNA acts as a potent damage-associated molecular pattern (DAMP) when released into the cytosol, triggering innate immune responses via the cGAS-STING pathway (PubMed, 2020). In autoimmune conditions like systemic lupus erythematosus (SLE), dsDNA is a major autoantigen, and the presence of anti-dsDNA antibodies is a hallmark diagnostic marker (Mayo Clinic, 2023). While effective, targeting dsDNA often lacks specificity for cancer cells, leading to significant side effects such as bone marrow suppression and the risk of secondary cancers (American Cancer Society, 2022).

Other names
Genomic DNANuclear DNAMitochondrial DNADouble-helical DNADeoxyribonucleic acid
02

Mechanism of action

DNA alkylation, DNA intercalation, DNA cross-linking, DNA strand breakage, and minor groove binding.

03

Biological functions

Genetic information storageDNA replicationTranscriptionDNA repairCell division
04

Disease associations

CancerSystemic lupus erythematosusInfectionGenetic disordersAutoimmune disease
05

Safety considerations

Secondary malignanciesMyelosuppressionTeratogenicityMutagenicityCardiotoxicityInfertility
06

Interacting drugs

Cisplatin

9 more in the full profile.

07

Biomarkers

Anti-dsDNA antibodiesgamma-H2AX8-hydroxy-2'-deoxyguanosine (8-OHdG)Circulating tumor DNA (ctDNA)

Beyond the preview

Go deeper on Cellular double-stranded DNA (dsDNA) (dsDNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular double-stranded DNA (dsDNA) (dsDNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call